Kent Pharmaceuticals has over 1,000 parallel import product licences (PIPLs) spanning 9 countries, Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Portugal and Spain.

Our newly built repackaging unit is capable of producing 750,000 packs per month.

Registration of new products is key and essential for our future growth. To do this we have a Regulatory Department busy processing new applications and handling variations but, more importantly, researching the market looking for those new 'blockbusters'.

We are always on the lookout for new product launches throughout Europe and for new business partners to supply them.